-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Galectin Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2024.
- Galectin Therapeutics Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$7.69M, a 36.5% increase year-over-year.
- Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$41.8M, a 26.7% decline from 2023.
- Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$33M, a 6.15% decline from 2022.
- Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$31.1M, a 27.8% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)